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Positron Emission Tomography (PET) in Male
and Female Rats
Jürgen W. A. Sijbesma, Aren van Waarde , David Vállez García, Hendrikus H. Boersma,
Riemer H. J. A. Slart, Rudi A. J. O. Dierckx, Janine Doorduin
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1,
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Abstract
Purpose: An important issue in rodent imaging is the question whether a mixed population of male
and female animals can be used rather than animals of a single sex. For this reason, the present
study examined the test-retest stability of positron emission tomography (PET) with 2-deoxy-2-
[18F]fluoro-D-glucose ([18F]FDG) in male rats and female rats at different phases of the estrous cycle.
Procedures: Long–Evans rats (age 1 year) were divided into three groups: (1) males (n = 6), (2)
females in metestrous (low estrogen levels, n = 9), and (3) females in proestrous (high estrogen
levels, n = 7). Two standard [18F]FDG scans with rapid arterial blood sampling were made at an
interval of 10 days in subjects anesthetized with isoflurane and oxygen. Body temperature, heart
rate, and blood oxygenation were continuously monitored. Regional cerebral metabolic rates of
glucose were calculated using a Patlak plot with plasma radioactivity as input function.
Results: Regional metabolic rate of glucose (rCMRglucose) in male and female rats, or [
18F]FDG
uptake in females at proestrous and metestrous, was not significantly different, but females
showed significantly higher standardized uptake values (SUVs) and Patlak flux than males,
particularly in the initial scan. The relative difference between the scans and the test-retest
variability (TRV) were greater in females than in males. Intra-class correlation coefficients (ICCs)
of rCMRglucose, SUV, normalized SUV, and glucose flux were good to excellent in males but poor
to moderate in females.
Conclusions: Based on these data for [18F]FDG, themixing of sexes in imaging studies of the rodent
brain will result in an impaired test-retest stability of PET data and a need for larger group sizes to
maintain statistical power in group comparisons. The observed differences between males and
females do not indicate any specific gender difference in cerebral metabolism but are related to
different levels of non-radioactive glucose in blood plasma during isoflurane anesthesia.
Key words: Small animal imaging, Regional cerebral metabolic rate of glucose, Gender
differences, Test-retest stability, Estrogens
Introduction
An important issue in rodent imaging is the question
whether a mixed population of female and male animals
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can be used, rather than animals from a single sex. The
inclusion of both sexes in study protocols might lead to a
reduction of the number of surplus animals since experi-
mental animals of the currently undesired sex would no
longer need to be excluded. In order to assess the impact of
gender mixing on the variability of preclinical positron
emission tomography (PET) data, we here report the results
of repeated, quantitative 2-deoxy-2-[18F]fluoro-D-glucose
([18F]FDG) scans of the brain of adult rats.
Many reports on gender differences of glucose metabo-
lism in the human brain have been published in the past
decades, but the results have been conflicting. Some studies
reported that global metabolic rate in the female brain is
higher than in males, and possibly related to estrogen levels
[1–3]. Other studies noted the mentioned difference in
patients during motor activity but not in healthy subjects
[4], or observed no differences between the sexes [5–8].
When regional rather than global rates of glucose
consumption were measured in the human brain, gender
differences were frequently observed but the nature of these
differences and the involved brain areas were divergent.
According to one study, temporal-limbic regions and
cerebellum consume more glucose in men than in women,
whereas cingulate is more active in women than in men [9].
Other studies reported opposite findings: temporal poles and
cerebellum being metabolically more active in females than
in males [8], or posterior parts of the brain being more active
in females whereas anterior brain is more active in males
[10]. Voxel-based rather than region of interest (ROI)-based
methods indicated that the male brain has significantly
higher glucose consumption in the right insula, middle
temporal gyrus, and medial frontal lobe, whereas the female
brain has a significantly higher metabolic rate in the
hypothalamus [11]. A study using statistical parametric
mapping (SPM) reported that metabolism in visual cortex
and cerebellum is significantly higher in males than in
females [12].
When gender differences are studied in experimental
animals rather than humans, the subjects can be scanned in a
carefully controlled way: at the same age, at a well-defined
phase of the estrous cycle, at similar levels of oxygenation,
and in the anesthetized rather than the awake state. Inter-
individual differences related to breathing, diet, or con-
sciousness can thus be avoided, and observed differences in
brain metabolism can be more easily related to other
physiologic parameters. Test-retest studies of cerebral
[18F]FDG-PET in rodents with arterial blood sampling have
been performed by various groups, but only male animals
were included in these studies [13, 14].
If global or regional differences in glucose metabolism,
such as have been reported for the human brain, would also
exist in rodents, gender mixing would result in significant
increases of inter-individual variability in preclinical studies
and would complicate the detection of group differences.
Since age is known to have a significant (and possibly a
gender-related) impact on cerebral metabolism [15] and
since glucose consumption in the brain may be positively
correlated to estrogen levels [1], we planned our animal
study in the following way: All animals were of the same
age, and were either males or females at two different phases
of the estrous cycle (proestrous or metestrous, i.e., at high or
low levels of circulating estrogens). All animals were
scanned again after an interval of two estrous cycles, which
is on average 10 days in a female rat. Our study aimed to
examine the test-retest stability of [18F]FDG-PET in male
and female rodents. Secondary research questions were as
follows: Are gender differences of cerebral glucose metab-
olism detectable in rats, and is the cerebral uptake of
[18F]FDG in female rats related to estrogen levels?
Materials and Methods
Reagents
[18F]FDG was produced by the Hamacher method [16].
Radiochemical purity of the product was virtually 100 %.
Animals
The study protocol complied to European Directive 2010/63/
EU and the Law on Animal Experiments of The Nether-
lands; it was approved by the Central Committee on Animal
Experiments of The Netherlands (The Hague, license no.
AVD105002015166) and the Institutional Animal Care and
Use Committee of the University of Groningen (protocol
15166-01-001). The experiments described in this paper are
reported in compliance with the ARRIVE guidelines. We
used 22 Long–Evans rats (HsdBlu:LE, age 1 year) which
were born at the Central Animal Laboratory of the
University Medical Center Groningen. The animals were
housed in Makrolon cages on a layer of wood shavings at a
temperature of 21 ± 2 °C under a fixed 12-h light–dark
regime. Standard laboratory chow (RMH-B, Hope Farms,
The Netherlands) and water were available ad libitum.
Information concerning the rats (body weights at the
moments of scanning, injected tracer dose, blood glucose
levels) is provided in Table 1. At the beginning of the study
(day of the first PET scan), the animals were divided into
three groups: (1) females at proestrous (high estrogen
levels), (2) females at metestrous (low estrogen levels), and
(3) males. The group size was estimated based on previously
obtained [18F]FDG-PET data in ovariectomized female rats,
treated with placebo or estradiol. Assuming an alpha of 0.05
and a power of 0.8, the calculated group size ranged from 5
to 10 depending on brain region and duration of estradiol
treatment. For the first PET scan, male rats were randomly
chosen. Random selection of all animals in this study was
not possible since rats were selected for scanning based on
their gender and (for females) the actual phase of the estrous
cycle. When animals had been scanned for the first time, the
date of their second scan was fixed.
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Vaginal Smears
In order to determine the length of the estrous cycle in each
female rat, vaginal smears were taken daily (before 10:00 h)
for at least 15 consecutive days (about 3 cycles). An
additional vaginal smear was taken on the day of the first
PET scan. A maximum of 20 vaginal smears was obtained
from a single rat, using an eyedropper tool. The eyedropper
pipette was filled with 0.2 ml of saline and was inserted
approximately 5 mm into the rat’s vagina. The saline was
quickly released from the dropper and then immediately
drawn back into the pipette. Saline samples containing cells
from the vaginal wall were placed on a microscope slide and
were examined at ×100 magnification to determine the phase
of the cycle [17].
PET Scanning
All PET scans were made between 11.30 and 14.00 h,
i.e., near the middle of the animal’s 12-h daylight period.
The investigators who made the scans (JWAS, AvW)
were blinded for the estrous phase of female rats, which
had been determined by JD. On the day of the first PET
scan, rats were anesthetized with isoflurane in 95 %
oxygen (5 % isoflurane for induction and 2 % for
maintenance). A cannula was placed in a side branch of
the femoral artery, using a surgical procedure which was
developed in our laboratory and was published previ-
ously [18]. A second cannula was placed in a tail vein.
The venous cannula was used for tracer injection and the
arterial cannula for blood sampling during the scan. All
surgical actions were performed under aseptic conditions.
After this surgery, a small sample of blood was drawn
from the arterial cannula. Blood glucose in this sample
was determined enzymatically, with hexokinase and
glucose-6-phosphate dehydrogenase. The rat was then
positioned in the small animal PET camera (Siemens/
Concorde MicroPET Focus 220) with its brain in the
field of view. A transmission scan of 515 s was made,
using a 57Co point source, for later correction of
attenuation and scatter of 511 keV gamma radiation by
tissue. Subsequently, the tracer [18F]FDG was injected
during a period of 1 min, using an injection pump
(Harvard Apparatus, Holliston, MA, USA). Data acqui-
sition of the PET camera (list mode protocol) was started
simultaneously with activation of the pump. During the
PET scan of 60 min, 15 arterial blood samples (volume
0.1–0.15 ml) were taken at the following intervals: 10,
20, 30, 40, 50, 60, 90, 120, 180, 300, 450, 600, 900,
1800, and 3600 s. Using these samples, radioactivity in
25 μl of whole blood and 25 μl of plasma was
determined by ex vivo gamma counting. Heating pads
and electronic temperature controllers (M2M Imaging,
Cleveland, OH, USA) were used to maintain the body
temperature of the rat close to the normal value (i.e.,
between 37 and 38 °C) during surgery and PET
scanning. Body temperature of the animal was continu-
ously registered, using a rectal PTC thermometer and a
data logging system (PicoTechnology, St. Neots, UK).
Heart rate and oxygen level of the blood were contin-
uously monitored, using a pulse oximeter (PulseSense,
Nonin Medical, Plymouth, MN, USA). Eye salve was
applied to prevent dehydration of the cornea. After the
PET scan, the cannulas were removed. The side branch
of the femoral artery was closed and the surgical wound
in the hind leg was stitched. Analgesia was applied to
reduce animal discomfort (subdermal Marcaine 0.5 %,
2.5 mg/kg). Animals were returned to their (pre-warmed)
home cages to wake up from anesthesia and were
Table 1.. Animal and scan data
Sex Female Male
Number of animals 16 6
Body weight (g) at scan 1 394 ± 54 658 ± 46*
Body weight (g) at scan 2 385 ± 49$ 636 ± 50*$
Injected dose (MBq) at scan 1 40.2 ± 3.7 37.5 ± 4.3
Injected dose (MBq) at scan 2 37.7 ± 7.1 36.0 ± 3.7








Blood glucose (mmol/l) at scan 1 11.0 ± 1.4 15.9 ± 2.8*
Blood glucose (mmol/l) at scan 2 10.7 ± 1.5 14.3 ± 2.1*
Interval between anesthesia induction and scan 1 (min) 51 ± 9 52 ± 6
Interval between anesthesia induction and scan 2 (min) 40 ± 8 43 ± 5
Interval between scans (days) 10.0 ± 0.4 10.5 ± 1.2
Data are reported as mean ± SD. Significant differences are indicated: *P G 0.001 (male vs. female), $P G 0.001 (retest vs. test)
P proestrous, E estrous, M metestrous, D diestrous, n.a. not applicable
Sijbesma J.W.A. et al.: Gender differences in FDG-PET of the brain
allowed at least 9 days for recovery. During this period,
they were examined at regular intervals to examine the
status of the wound and to score their behavior and
condition. Unexpected complications (uncontrollable
bleeding, signs of paralysis, disturbed mobility, signifi-
cant weight loss) were not encountered.
A second PET scan was made of each animal after an
interval of 9 to 13 (in most cases 10) days, using the same
procedure as described for scan 1, but after this scan, the
animals were euthanized by extirpation of the heart, under
deep isoflurane anesthesia.
Data Analysis
The list mode data of the emission scans were reframed
into a dynamic sequence of 6 × 10 s, 4 × 30 s, 2 × 60 s,
1 × 120 s, 1 × 180 s, 4 × 300 s, and 3 × 600 s frames. The
data were reconstructed per time frame, using an iterative
reconstruction algorithm (ordered subsets expectation
maximization, OSEM 2D with Fourier rebinning, 4
iterations and 16 subsets). The final datasets consisted
of 95 slices with a slice thickness of 0.8 mm and an in-
plane image matrix of 256 × 256 pixels. The voxel size
was 0.63 × 0.63 × 0.80 mm and the linear resolution at
the center of the field of view 1.5 mm. Data sets were
corrected for decay, random coincidences, scatter, and
attenuation.
Independent female and male rat FDG-PET brain
templates were constructed [19], each aligned to the same
MRI template [20]. Individual rat brain images where
aligned to the appropriate sex-specific template using
rigid-body transformation and the software package
PMOD (version 3.804). As confirmed by comparison on
CT images, the male brains were about 5 % bigger than
the brains of females. Accordingly, the ROIs where
linearly scaled (5 %) to accommodate the bigger male
brain. Nine ROIs, whole brain including cerebrospinal
fluid space, cerebellum, mesencephalon, pons, striatum,
cerebral cortex, hippocampus, hypothalamus, and thala-
mus, were defined based on the MRI template. Time-
activity curves (TACs) were calculated for the entire brain
and for these brain regions. Calculated SUVs of tracer
uptake in these ROIs were either uncorrected or normal-
ized for the blood glucose level, using the formula:
SUVcorr = [SUV x blood glucose (mmol/l)] / [Average
blood glucose for the entire gender group]. Glucose influx
rate (slope) and regional cerebral metabolic rates of
glucose were calculated by Patlak graphical analysis [21,
22]. The fit was started at 10 min after tracer injection and
the Akaike information criterion was smallest if cerebral
blood volume was fixed at 5.0 %, a value reported in the
literature [23]. Radioactivity in arterial plasma was used as
input function, and radioactivity in whole blood was
employed to estimate the contribution of radioactivity in
blood to measured activity in the brain.
Statistics
The reproducibility of measurements performed in the same
animal at test and retest was calculated as a relative
difference (Eq. 1) and as TRV (Eq. 2): [24].
Relative difference ¼ 100* Retest=Testð Þ−100 ð1Þ
TRV ¼ 100* Test‐Retest½ = Testþ Retestð Þ=2½  ð2Þ
Measurement variability was expressed as coefficient of
variance (COV; Eq. 3):
COV ¼ 100* Standard Deviation=Meanð Þ ð3Þ
The reliability of the measurements (mean square
between subjects, MSBS, and mean square within subjects,
MSWS) was expressed as ICC (Eq. 4):
ICC ¼ MSBS−MSWS½ = MSBSþ n−1ð Þ*MSWS½  ð4Þ
We used the two-way mixed model with the absolute
agreement type and a confidence interval of 95 % to
calculate ICC [25]. The generalized estimating equations
model was used to account for the repeated measurements in
the design and a few missing data for heart rate and blood
oxygenation. The independent correlation matrix was se-
lected for the analysis, and P values reported using the
Wald test. P G 0.05, without correction for multiple comparisons,
was considered statistically significant.
Results
Glucose Metabolic Rate and Flux
The rCMRglucose of whole brain was similar in female and
male rats (18.3 ± 0.6 vs. 19.1 ± 2.0) but was significantly
higher at scan 1 than at scan 2 (20.8 ± 1.4 vs 16.6 ± 0.8,
P G 0.001). Similar, statistically significant differences be-
tween the scans were observed in all studied brain areas (see
Fig. 1a and Supplementary Table 1). Significant differences
in rCMRglucose of the female brain at proestrous and
metestrous were not detected.
Glucose flux in whole brain was higher in females than in
males (0.016 vs 0.012, P = 0.002) and was higher at scan 1
than at scan 2 (0.015 vs. 0.013, P G 0.001). Similar,
statistically significant, differences between the sexes and,
for females, between the scans were observed in all studied
brain areas (Fig. 1b and Supplementary Table 2 (see
electronic supplementary material (ESM)). Significant
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differences in regional glucose flux of female brain at
proestrous and metestrous were not detected, with cerebel-
lum as the only exception (0.019 vs. 0.016, P G 0.02).
SUV and Normalized SUV
TACs of F-18 in whole brain and blood plasma after
injection of [18F]FDG are shown in Fig. 2. PET images of
the brain of a representative female and male rat are
presented in Fig. 3.
SUV values for whole brain were higher in females than
in males (3.08 ± 0.15 vs. 2.46 ± 0.24 (Fig. 2a and Supple-
mentary Table 3 in ESM) and were higher at scan 1 than at
scan 2 (2.87 ± 0.15 vs. 2.66 ± 0.15, P G 0.05). If smaller brain
areas were analyzed, the same trends were observed but the
sex difference reached statistical significance only in
cerebellum, hypothalamus, mesencephalon, and pons and
the scan difference in cortex, hippocampus, hypothalamus,
mesencephalon, pons, and thalamus. Normalized SUV
values for whole brain tended to be higher in females than
in males (3.07 ± 0.17 vs. 2.45 ± 0.27, P = 0.054) and were
higher at scan 1 than at scan 2 (2.95 ± 0.19 vs 2.57 ± 0.15,
P = 0.001 (Fig. 2b and Supplementary Table 4 in ESM)).
Significant differences between uncorrected or normalized
SUV values for whole brain or for individual brain regions
of female rats at proestrous and metestrous were not detected
(Fig. 4).
In order to explore a factor which might affect apparent
metabolic rates of glucose, we tested whether there was any
significant correlation between [18F]FDG uptake in the brain
and body weight.
In the range of body weights examined in this study, we
did not observe significant correlations between any calcu-
lated parameter of cerebral glucose uptake and body weight.
Physiological Parameters
An overview of some physiological parameters of the
animals during the PET scans is provided in Fig. 5. Since
no significant differences of body temperature, heart rate, or
blood oxygenation were noted between scan 1 and scan 2,
Fig. 5 shows pooled data from both scans. The core
temperature of female rats (measured with a rectal PTC
thermometer) was slightly higher than that of males (37.4 ±
0.1 vs 36.8 ± 0.1 °C, mean ± SEM, P G 0.001) and tended to
rise during the scan (Fig. 5a). In contrast to the core
temperature, the temperature of the extremities (not mea-
sured) seemed to drop more in females than in males,
resulting in pale hind paws in females and occasional
difficulties in recording oxygenation with a pulse oximeter.
Heart rate of all animals declined during the scan, probably
as a consequence of prolonged anesthesia. This effect of
time was statistically significant (P G 0.02), but the differ-
ence between the sexes did not reach statistical significance,
although heart rate tended to drop more in females than in
males (Fig. 5b). Finally, male rats maintained higher
oxygenation levels in their blood than females (95.8 ± 0.4
vs 93.8 ± 0.4 %, P = 0.001, Fig. 5c). Although the observed
differences were minor, the physiological condition of male
rats during the scan appeared to be more stable than that of
females.
Levels of blood glucose were 34 to 45 % higher in male
rats than in females (Table 1) and were also higher in scan 1
than in scan 2 (overall 13.4 ± 0.6 vs. 12.5 ± 0.5 mg/ml,
P G 0.02). At the age of 1 year that was chosen in this study,
male rats were considerably heavier than females (Table 1).
All animals lost some weight during the 10-day interval
between the scans. The average loss was 9 g for females and
22 g for males, representing 2.3 to 3.3 % of their initial body
weights.
For the test scan, we managed to select seven female rats
in proestrous and nine females in metestrous (Table 1).
Based on the length of the estrous cycle in each individual
(which we had determined during a period of 15 days prior
to scan 1), we expected a similar ratio of females in
Fig. 1. a rCMRglucose and b glucose flux in whole brain,
cortex, and cerebellum at test and retest. Solid bars indicate
data of male, and hatched bars data of female rats, plotted
as mean ± SD. * = Significantly different from the test value;
+ = significantly different from the corresponding value in
males.
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proestrous and metestrous at scan 2, which was made after
an interval of 9 to 13 days (in most cases, 10 days).
However, due to variability of the cycle length, some
females were not in proestrous or metestrous at retest. Two
were in proestrous and six were in metestrous, but two
others were in estrous (sexually receptive, rising estrogen
level) and six in diestrous (sexually quiescent, low estrogen
level) by the time of the second scan (Table 1).
Test-Retest Stability
Relative differences between test and retest besides TRV,
COV, and ICC values for the parameters SUV, normalized
SUV, glucose flux, and rCMRglucose are reported in the ESM
Tables and in Fig. 6. These data indicate a greater relative
difference between the scans and a greater TRV in females
than in males. The most dramatic difference between the
sexes was noted when ICC was calculated. Whereas male
rats showed good to excellent values for the ICC of whole
brain SUV (0.96), normalized SUV (0.92), flux (0.93), and
rCMR (0.78), female rats showed moderate to poor ICC
values for the same parameters (0.60, 0.61, 0.40, and 0.23,
respectively). Similar gender differences were noted in all
studied brain areas. Thus, the reproducibility of measure-
ments of cerebral glucose metabolism was considerably
better in males than in females.
Discussion
In brain tissue of isoflurane-anesthetized male rats and mice,
metabolic rates of 23 ± 3 and 24 ± 6 μmol glucose/min/100 g
Fig. 2. Time-activity curves for [18F]FDG uptake in a whole brain and b plasma at scan 1 and idem at scan 2 (c and d,
respectively). Open symbols indicate data for female rats, whereas closed symbols concern males. Data plotted as mean ±
SEM.
Fig. 3. Coronal [18F]FDG-PET images of the brain of (a, b) a
female and (c, d) male rat (test, retest). The images represent
data summed from 5 to 60 min after injection, and the outline
of the brain is indicated by a dotted line.
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have been reported [26, 27]. Our estimate of 20.8 ±
1.4 μmol/min/100 g at the first scan corresponds closely to
these literature values. Published test-retest studies for
[18F]FDG-PET in rat brain involved a small number of
conscious animals and concerned only males. In these
studies, rCMRglucose was reported as 99.6 ± 10.2 μmol/min/
100 g [14] and relative differences between retest and test in
various brain regions ranged from −7 to +10 % [13]. Our
measurements of cerebral rCMRglucose in anesthetized male
(19.1 ± 2.0) and female (18.3 ± 0.6) rats showed similar
standard deviations (maximally 10 % of the mean), but we
observed greater differences between retest and test, ranging
from −12 to −22 %. This last observation may be due to the
fact that we included animals from both sexes, and female
rats showed greater differences between retest and test than
males (Fig. 4a).
Although we did not observe any significant differ-
ence in cerebral rCMRglucose of male and female rats or
in rCMRglucose of female rats at proestrous and
metestrous, the sexes showed different values for SUV,
normalized SUV, and glucose influx. We noted higher
values for these parameters in females, as was reported
previously in some studies of [18F]FDG uptake in the
human brain [1–3]. Moreover, these parameters showed
higher values at test than at retest. If we quantified
regional rather than whole brain SUV or glucose influx,
similar differences between the sexes or scans were
noted in all studied brain regions. This global character
of the observed phenomena suggests that tracer input
was different in males and females, and at retest and test.
Since rCMRglucose did not show any differences, the
detected differences of SUV, normalized SUV, and
glucose flux appear to be related to altered levels of
non-radioactive glucose in blood plasma.
Fig. 4. a SUV and b normalized SUV of [18F]FDG in whole
brain, cortex, and cerebellum at test and retest. Solid bars
indicate data of male, and hatched bars data of female rats,
plotted as mean ± SD. * = Significantly different from the test
value; + = significantly different from the corresponding value
in males.
Fig. 5. Time course of: a rectal temperatures, b heart rate,
and c oxygenation of the blood during the PET scans. Open
symbols indicate data for female rats, whereas closed
symbols concern males. Data plotted as mean ± SEM.
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The physiological data that we recorded during our scans
indicate that male and female rodents respond differently to
the conditions which are encountered in small animal PET.
Body temperature, heart rate, and blood oxygenation were
more stable in males than in females during prolonged
isoflurane anesthesia, although the observed differences
between the sexes were small. Blood glucose levels during
the scan were also different, namely higher in males than in
females.
The relative difference between the scans and the TRV of
rCMRglucose and all other calculated parameters of cerebral
glucose metabolism were greater in females than in males.
Moreover, the ICC of these parameters was good to
excellent in males but poor to moderate in females. The
test-retest stability of [18F]FDG-PET was thus considerably
greater in male than in female rats.
Conclusion
This study has several limitations: It involved only a single
tracer, a single form of anesthesia, a single rodent species,
and animals at a single age. Thus, our findings cannot be
generalized, particularly not to other tracers, other biochem-
ical processes or awake rats. However, our findings support
the hypothesis that female rats show greater variability than
male rats in small animal imaging. Based on these results for
[18F]FDG in anesthetized rats, the mixing of sexes in rodent
imaging will result in an impaired test-retest stability of PET
data and a need for larger group sizes to maintain the same
statistical power in group comparisons.
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Fig. 6. a, b ICC values and c, d relative difference between retest and test for rCMRglucose and SUV in whole brain, cortex, and
cerebellum. Solid bars indicate data of male, and hatched bars data of female rats.
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